Results 31 to 40 of about 19,278,359 (237)

Classical Complement Pathway Inhibition in a Pediatric Patient With Refractory Immune Thrombocytopenia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric refractory immune thrombocytopenia (rITP) is generally characterized by persistent thrombocytopenia and failure to achieve a sustained response to multiple standard therapies. We report a 4‐year‐old female with congenital tufting enteropathy, post‐intestinal transplant patient on immunosuppressants, who developed severe rITP ...
Sarah Hsieh   +4 more
wiley   +1 more source

Anti-HEV immunoglobulin G seroprevalence among persons who use drugs (n = 200).

open access: yes, 2018
Anti-HEV immunoglobulin G seroprevalence among persons who use drugs (n = 200).
F. R. Zuure (6091331)   +7 more
core   +1 more source

Production of Rabbit Anti-Rabies Immunoglobulin Using Cultural Antigen [PDF]

open access: yes, 2012
Justified is the possibility of application of fixed rabies virus Moscow 3253, reproduced on the cell culture Vero, as an antigen for heterologous anti-rabies immunoglobulin production.
Zh. V. Matveeva   +11 more
core   +1 more source

Abatacept for Prophylaxis of Acute and Chronic Graft‐Versus‐Host‐Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Systematic Review and Meta‐Analysis of Cohort Studies

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Cell Structures in Heterologous Anti-Rabies Immunoglobulin Production [PDF]

open access: yes, 2011
This paper reviews basic modern trends in obtainment of anti-rabies immunoglobulin with enhanced properties. One of these trends is associated with the substitution of organ-tissue antigen by cultural antigen at the stage of producer immunization ...
Zh. V. Matveeva   +3 more
core   +1 more source

Effect of DFPP on Ferroptosis in Peripheral Blood CD14+ Monocytes of Hyperlipidemic Patients Involving the ACSL4/LPCAT3/ALOX5 Pathway

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng   +3 more
wiley   +1 more source

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

open access: yesFEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

Anti-HEV immunoglobulin G (IgG) seroprevalence among men who have sex with men (n = 197).

open access: yes, 2018
Anti-HEV immunoglobulin G (IgG) seroprevalence among men who have sex with men (n = 197).
F. R. Zuure (6091331)   +7 more
core   +1 more source

Production of Lyophilized Preparation of Anti-Rabies Immunoglobulin and Examination of Its Main Properties [PDF]

open access: yes, 2011
Presented are data on examination of physical, chemical and biological characteristics of lyophilized preparation of geterologous anti-rabies immunoglobulin. Dry and original liquid forms of immunoglobulin were comparatively analyzed.
L. V. Savitskaya   +12 more
core   +1 more source

Determination of quality criteria for candidate standard for anti-D immunoglobulin

open access: yesСибирский научный медицинский журнал
Quality control of medicines is an integral part of the technological cycle, obligatory for the release of products into public distribution. Both in Russia and abroad, when carrying out of laboratory testing of the preparations, it is prescribed to use ...
E. N. Kalinina   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy